The best way to keep up to date with all of the latest cutting edge technologies from the lab to the market! Movers & Shakers Issue 9, 2020 Join SCI Movers and Shakers article Society of Chemical Indu...
The best way to keep up to date with all of the latest cutting edge technologies from the lab to the market! Movers & Shakers Join SCI Movers and Shakers article industry, appointments, chemical, jobs...
Lisa von Moltke, former acting senior VP and head of clinical development at US global biotechnology company Alkermes, has moved to Seres Therapeutics as CMO. The Boston-headquartered biotechnology company Seres focuses on drugs to treat infectious, metabolic, and inflammatory diseases by targeting the underlying biology of the human microbiome.
US biotechnology company Altavant Sciences, which focuses on drug development for rare respiratory diseases, has appointed Howard M. Lazarus as CMO. Lazarus has over 20 years’ experience in drug development for pulmonary, vascular and interstitial diseases.
The best way to keep up to date with all of the latest cutting edge technologies from the lab to the market! Movers and shakers Join SCI The American Cleaning Institute, based in Washington DC, which ...
The American Cleaning Institute, based in Washington DC, which represents the US cleaning products industry, has promoted James Kim to VP, science regulatory affairs, and Kathleen Stanton to associate VP, technical & internal affairs. These promotions follow the retirement of Richard Sedlak, executive VP, technical & internal affairs.
AMRI, a global pharmaceutical CDMO headquartered in Albany, New York, has appointed LabCorp’s John Ratliff as CEO. He succeeds Michael Mulhern, who has been appointed chairman of the AMRI board of directors.
Miles D. White is stepping down as CEO of US global healthcare company Abbott, headquartered in Illinois, but will remain as executive chairman. He will be succeeded by president and COO of the company Robert B. Ford, who has also been elected to the board.
Chinese biotechnology firm Ascletis Pharma, which focuses on antiviral, cancer and fatty acid diseases, has appointed former Novartis global head Handan He as CSO.